Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sodium channel therapy for Crohn's-associated diarrhea was terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sodium channel therapy

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Crohn's Disease, Inflammatory Bowel Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-02-06